Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Pediatric Scoliosis Surgery
NCT01813058Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Jan 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in adolescent idiopathic scoliosis (AIS) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Perioperative Blood Loss. Started Jan 2013; status: completed.
02
Drugs
tranexamic acid
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on NCT01813058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01813058.